Non-surgical management of erectile dysfunction

Clinical Endocrinology

Volumn 52, Issue 3, 2000, Pages 253-260

  Levy, Andy ^a   Crowley, Tessa ^a   Gingell, Clive ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA INTERMEDIN DERIVATIVE; AMINOPHYLLINE; AMYL NITRITE; APOMORPHINE; BROMOCRIPTINE; CLOMIPRAMINE; DIHYDROERGOTOXINE MESILATE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; LINSIDOMINE; MOXISYLYTE; NITRATE; NITROPRUSSIDE SODIUM; OPIATE DERIVATIVE; PAPAVERINE; PAROXETINE; PHENTOLAMINE; PRASTERONE; PROLACTIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; TESTOSTERONE; TRAZODONE; UNINDEXED DRUG; VASOACTIVE AGENT; YOHIMBINE;

ANDROGEN THERAPY; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DRUG COMPETITION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; ERECTILE DYSFUNCTION; HORMONE DEFICIENCY; HUMAN; HYPERPROLACTINEMIA; IONTOPHORESIS; PATHOGENESIS; PENIS ERECTION; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; UROLOGIC SURGERY;

ADMINISTRATION, TOPICAL; ALPROSTADIL; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NITRATES; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PSYCHOTHERAPY; TESTOSTERONE; VACUUM; VASODILATOR AGENTS;

EID: 0034073778     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00954.x     Document Type: Review

References (103)

1. Aldridge, J. & Measham, F. (1999) Sildenafil (Viagra) is used as a recreational drug in England. Lancet, 353, 340-341.
2. Andersson, K.E. & Stief, C.G. (1997) Neurotransmission and the contraction and relaxation of penile erectile tissues. World Journal of Urology, 15, 14-20.
3. Anonymous (1998) Sildenafil. Summary of product characteristics, Pfizer Labs, New York. www.viagra.com/hcp/pro_pack_insert.htm
4. Araujo, A.B., Durante, R., Feldman, H.A., Goldstein, I. & McKinlay, J.B. (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosomatic Medicine, 60, 458-465.
5. Baltaci, S., Aydos, K., Kosar, A. & Anafarta, K. (1995) Treating erectile dysfunction with a vacuum tumescence device: a retro-spective analysis of acceptance and satisfaction. British Journal of Urology, 76, 757-760.
6. Becker, A.J., Stief, C.G., Machtens, S., Schultheiss, D., Hartmann, U., Truss, M.C. & Jones, U. (1998) Oral phentolamine as treatment for erectile dysfunction. Journal of Urology, 159, 1214-1216.
7. Bodansky, H.J. (1994) Treatment of male erectile dysfunction using the active vacuum assist device. Diabetic Medicine, 11, 410-412.
8. Sildenafil, a novel effective oral therapy for male erectile dysfunction. British Journal of Urology, 78, 257-261.
9. Bosshardt, R.J., Farwerk, R., Sikora, R., Sohn, M. & Jakse, G. (1995) Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. British Journal of Urology, 75, 786-791.
10. Brindley, G.S. (1983) Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. British Journal of Psychiatry, 143, 332-337.
11. Burnett, A.L. (1997) Nitric oxide in the penis: physiology and pathology. Journal of Urology, 157, 320-324.
12. Burnett, A.L., Johns, D.G., Kriegsfeld, L.J., Klein, S.L., Calvin, D.C., Demas, G.E., Schramm, L.P., Tonegawa, S., Nelson, R.J., Snyder, S.H. & Poss, K.D. (1998) Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. Nature Medicine, 4, 84-87.
13. Buvat, J., Costa, P., Morlier, D., Lecocq, B., Stegmann, B. & Albrecht, D. (1998) Double-blind multicentre study compairing alprostadil alpha-cyclodextrin with Moxisylyte chlorhydrate in patients with chronic erectile dysfunction. Journal of Urology, 159, 116-119.
14. Buvat, J. & Lemaire, A. (1997) Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. Journal of Urology, 158, 1764-1767.
15. Buvat, J., Lemaire, A., Buvat-Herbaut, M. & Marcolin, G. (1989) Safety of intracavernous injections using an alpha-blocking agent. Journal of Urology, 141, 1364-1367.
16. Buvat, J., Lemaire, A. & Ratajczyk, J. (1996) Role of hormones in sexual dysfunctions, homosexuality, transsexualism and deviant sexual behavior: diagnostic and therapeutic consequences. Contraception Fertilité Sexualité, 24, 834-846.
17. Carani, C., Granata, A.R., Bancroft, J. & Marrama, P. (1995) The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Psychoneuroendocrinology, 20, 743-753.
18. Carani, C., Granata, A.R., Fustini, M.F. & Marrama, P. (1996) Prolactin and testosterone: their role in male sexual function. International Journal of Andrology, 19, 48-54.
19. Carey, M.P. & Johnson, B.T. (1996) Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations. Archives of Sexual Behavior, 25, 341-360.
20. Champion, H.C., Wang, R., Santiago, J.A., Murphy, W.A., Coy, D.H., Kadowitz, P.J. & Hellstrom, W.J. (1997) Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the feline erection model. Journal of Andrology, 18, 513-521.
21. Condra, M., Morales, A., Owen, J.A., Surridge, D.H. & Fenemore, J. (1986) Prevalence and significance of tobacco smoking in impotence. Urology, 27, 495-498.
22. Conti, C.R., Pepine, C.J. & Sweeney, M. (1999) Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. American Journal of Cardiology, 83, 29C-34C.
23. Costabile, R.A. & Spevak, M. (1999) Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial. Journal of Urology, 161, 1819-1822.
24. Crowe, R., Burnstock, G., Dickinson, I.K. & Pryor, J.P. (1991) The human penis: an unusual penetration of NPY-immunoreactive nerves within the medial muscle coat of the deep dorsal vein. Journal of Urology, 145, 1292-1296.
25. Derry, F.A., Dinsmore, W.W., Fraser, M., Gardner, B.P., Glass, C.A., Maytom, M.C. & Smith, M.D. (1998) Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Neurology, 51, 1629-1633.
26. Dinsmore, W.W., Gingell, C., Hackett, G., Kell, P., Savage, D., Oakes, R. & Frentz, G.D. (1999a) Treating men with predominantly non-psychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptides naandd phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study. BJU International, 83, 274-279.
27. Dinsmore, W.W., Hodges, M., Hargreaves, C., Osterloh, I.H., Smith, M.D. & Rosen, R.C. (1999b) Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology, 53, 800-805.
28. Djamilian, M., Stief, C.G., Kuczyk, M. & Jonas, U. (1993) Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 and the treatment of erectile dysfunction. Journal of Urology, 149, 1296-1298.
29. Dorr, R.T., Lines, R., Levine, N., Brooks, C., Xiang, L., Hruby, V.J. & Hadley, M.E. (1996) Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 58, 1777-1784.
30. Dunsmuir, W.D. & Holmes, S.A.V. (1996) The aetiology and management of erectile, ejaculatory, and fertility problems in men with diabetes mellitus. Diabetic Medicine, 13, 700-708.
31. Ernst, E. & Pittler, M.H. (1998) Yohimbine for erectile dysfunction. A systematic review and meta-analysis of randomised clinical trials. Journal of Urology, 159, 433-436.
32. Fallon, B. (1995) Intracavernous injection therapy for male erectile dysfunction. Urology Clinics of North America, 22, 833-845.
33. Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J. & McKinlay, J.B. (1994) Impotence and its medical and psychological correlates: results of the Massachusetts male ageing study. Journal of Urology, 151, 54-61.
34. Ganem, J.P., Lucey, D.T., Janosko, E.O. & Carson, C.C. (1998) Unusual complications of the vacuum erection device. Urology, 51, 627-631.
35. Gerstenberg, T.C., Metz, P., Ottesen, B. & Fahrenkrug, J. (1992) Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure. Journal of Urology, 147, 1277-1279.
36. Gilbert, H.W. & Gingell, J.C. (1992) Vacuum constriction devices: second-line conservative treatment for impotence. British Journal of Urology, 70, 81-83.
37. Gingell, J.C. (1998a) New developments in self-injection therapy for erectile dysfunction. British Journal of Urology, 81, 599-603.
38. Gingell, J.C. (1998b) Use of intracavernosal alprostadil in erectile dysfunction. Hospital Medicine, 59, 777.
39. Goldstein, I., Lue, T.F., Padma-Nathan, H., Rosen, R.C., Steers, W.D. & Wicker, P.A. (1998) Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New England Journal of Medicine, 338, 1397-1404.
40. Gooren, L.J. (1987) Androgen levels and sex functions in testosterone-treated hypogonadal men. Archives of Sexual Behaviour, 16, 463-473.
41. Granata, A.R., Rochira, V., Lerchl, A., Marrama, P. & Carani, C. (1997) Relationship between sleep-related erections and testosterone levels in men. Journal of Andrology, 18, 522-527.
42. Gregoire, A. (1998) Viagra: on release. Evidence of the effectiveness of sildenafil is good. British Medical Journal, 317, 759-760.
43. Hawton, K. (1995) Treatment of sexual dysfunctions by sex therapy and other approaches. British Journal of Psychiatry, 167, 307-314.
44. Heaton, J.P., Morales, A., Adams, M.A., Johnston, B. & el-Rashidy, R. (1995) Recovery of erectile function by the oral administration of apomorphine. Urology, 45, 200-2006.
45. Hengeveld, M.W. (1998) Somatization of erectile disorders by the introduction of sildenafil. Nederlands Tijdschrift Voor Geneeskunde, 142, 2333-2336.
46. Hollander, J.B., Gonzalez, J. & Norman, T. (1992) Patient satisfaction with pharmacologic erection program. Urology, 39, 439-441.
47. Imagawa, A., Kimura, K., Kawanishi, Y. & Tamura, M. (1989) Effect of moxisylyte hydrochloride on isolated human penile corpus cavernosum tissue. Life Sciences, 44, 619-623.
48. ®): a cardiovascular overview. British Journal of Cardiology, 6, 325-334.
49. Kaplan, S.A., Reis, R.B., Kohn, I.J., Shabsigh, R. & Te, A.E. (1998) Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology, 52, 739-743.
50. Korenman, S.G., Morley, J.E., Mooradian, A.D., Davis, S.S., Kaiser, F.E., Silver, A.J., Viosca, S.P. & Garza, D. (1990) Secondary hypogonadism in older men: its relation to impotence. Journal of Clinical Endocrinology and Metabolism, 71, 963-969.
51. Krane, R.J., Goldstein, I. & Saenz de Tejada, I. (1989) Impotence. New England Journal of Medicine, 321, 1648-1659.
52. Lea, A.P., Bryson, H.M. & Balfour, J.A. (1996) Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction. Drugs Aging, 8, 56-74.
53. Leonard, M.P., Nickel, C.J. & Morales, A. (1989) Hyperprolactinemia and impotence: why, when and how to investigate. Journal of Urology, 142, 992-994.
54. Linet, O.I. & Ogrinc, F.G. (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New England Journal of Medicine, 334, 873-877.
55. Lottman, P.E., Hendriks, J.C., Vruggink, P.A. & Meuleman, E.J. (1998) The impact of marital satisfaction and psychological counselling on the outcome of ICI-treatment in men with ED. International Journal of Impotence Research, 10, 83-87.
56. Margolese, H.C. & Assalian, P. (1996) Sexual side effects of antidepressants: a review. Journal of Sexual Marital Therapy, 22, 209-217.
57. Marks, L.S., Duda, C., Dorey, F.J., Macairan, M.L. & Santos, P.B. (1999) Treatment of erectile dysfunction with sildenafil. Urology, 53, 19-24.
58. Martinez-Pineiro, L., Lopez-Tello, J., Alonso Dorrego, J.M., Cisneros, J., Cuervo, E. & Martinez-Pineiro, J.A. (1995) Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction. Journal of Urology, 153, 1487-1490.
59. Martinez-Pineiro, L., Trigo-Rocha, F., Hsu, G.L., Von Heyden, B., Lue, T.F. & Tanagho, E.A. (1993) Cyclic guanosine monophosphate mediates penile erection in the rat. European Urology, 24, 492-499.
60. Meinhardt, W., Schmitz, P.I., Kropman, R.F., de la Fuente, R.B., Lycklama a Nijeholt, A.A. & Zwartendijk, J. (1997) Trazodone, a double blind trial for treatment of erectile dysfunction. International Journal of Impotence Research, 9, 163-165.
61. Merrick, G.S., Butler, W.M., Lief, J.H., Stipetich, R.L., Abel, L.J. & Dorsey, A.T. (1999) Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology, 53, 1112-1116.
62. Montague, D.K., Barada, J.H., Belker, A.M., Levine, L.A., Nadig, P.W., Roehrborn, C.G., Sharlip, I.D. & Bennett, A.H. (1996) Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. Journal of Urology, 156, 2007-2011.
63. Montorsi, F., McDermott, T.E., Morgan, R., Olsson, A., Schultz, A., Kirkeby, H.J. & Osterloh, I.H. (1999) Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology, 53, 1011-1018.
64. Morales, A., Condra, M., Owin, J.A., Surridge, D.H., Fenemore, J. & Harris, C. (1987) Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. Journal of Urology, 137, 1168.
65. Morales, A., Gingell, C., Collins, M., Wicker, P.A. & Osterloh, I.H. (1998) Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction. International Journal of Impotence Research, 10, 69-73.
66. Morales, A., Johnston, B., Heaton, J.P. & Lundie, M. (1997) Testosterone supplementation for hypogonadal impotence: assessment of bio-chemical measures and therapeutic outcomes. Journal of Urology, 157, 849-854.
67. Mulligan, T. & Katz, P.G. (1989) Why aged men become impotent. Archives of Internal Medicine, 149, 1365-1366.
68. Naude, J.H. & Le Roux, P.J. (1998) Topical treatment of erectile dysfunction did not show results. British Medical Journal, 316, 1318.
69. Opsomer, R. J., Wese, F. X., De Groote, P. & Van Cangh, P. J. (1997) The external vacuum device in the management of erectile dysfunction. Acta Urologica Belgica, 65, 13-16.
70. Owen, J.A., Saunders, F., Harris, C., Fenemore, J., Reid, K., Surridge, D., Condra, M. & Morales, A. (1989) Topical nitroglycerin: a potential treatment for impotence. Journal of Urology, 141, 546-548.
71. Padma-Nathan, H., Hellstrom, W.J.G., Kaiser, F.E., Labasky, R.F., Lue, T.F., Nolten, W.E., Norwood, P.C., Peterson, C.A., Shabsigh, R. & Tam, P.Y. (1997) Treatment of men with erectile dysfunction with transurethral alprostadil. New England Journal of Medicine, 336, 1-7.
72. Padma-Nathan, H., Steers, W.D. & Wicker, P.A. (1998) Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. International Journal of Clinical Practice, 52, 375-379.
73. Pery, M., Rosenberger, A., Kaftori, J.K. & Vardi, Y. (1990) Intracorporeal calcifications after self-injection of papaverine. Radiology, 176, 81-83.
74. Porst, H. (1997) Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil - a comparative study in 103 patients with erectile dysfunction. International Journal of Impotence Research, 9, 187-192.
75. Porst, H. (1998) Transurethral alprostadil administration with MUSE (Medicated Urethral System for Erection). Current overview and personal experiences. Urologe Ausgabe, 37, 410-416.
76. Price, D.E., Gingell, J.C., Gepi-Attee, S., Wareham, K., Yates, P. & Boolell, M. (1998) Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabetic Medicine, 15, 821-825.
77. Ra, S., Aoki, H., Fujioka, T., Sato, F., Kubo, T. & Yasuda, N. (1996) In vitro contraction of the canine corpus cavernosum penis by direct perfusion with prolactin or growth hormone. Journal of Urology, 156, 522-525.
78. Rajfer, J., Aronson, W.J., Bush, P.A., Dorey, F.J. & Ignarro, L.J. (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New England Journal of Medicine, 326, 90-94.
79. Reid, K., Surridge, D.H., Morales, A., Condra, M., Harris, C., Owen, J. & Fenemore, J. (1987) Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet, 2, 421-423.
80. Reiter, W.J., Pycha, A., Schatzl, G., Pokorny, A., Gruber, D.M., Huber, J.C. & Marberger, M. (1999) Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology, 53, 590-594.
81. Rendell, M.S., Rajfer, J., Wicker, P.A. & Smith, M.D. (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. Journal of the American Medical Association, 281, 421-426.
82. Rosen, R.C. & Weiner, D.N. (1997) Cardiovascular disease and sleep-related erections. Journal of Psychosomatic Research, 42, 517-530.
83. Ryder, R.E., Close, C.F., Moriarty, K.T., Moore, K.T. & Hardisty, C.A. (1992) Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device. Diabetic Medicine, 9, 893-898.
84. Saenz de Tejada, I., Goldstein, T., Azadzoi, K., Krane, R.J. & Cohen, R.A. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New England Journal of Medicine, 320, 1025-1030.
85. Salmimies, P., Kockott, G., Pirke, K.M., Vogt, H.J. & Schill, W.B. (1982) Effects of testosterone replacement on sexual behavior in hypogonadal men. Archives of Sexual Behaviour, 11, 345-353.
86. Sato, F., Aoki, H., Nakamura, K., Taguchi, M., Aoki, T. & Yasuda, N. (1997) Suppressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apomorphine to pituitary-transplanted rats. Journal of Andrology, 18, 21-25.
87. Siegel-Itzkovich, J. (1998) Israel bans import of sildenafil citrate after six deaths in the US. British Medical Journal, 316, 1625.
88. Slag, M.F., Morley, J.E., Elson, M.K., Trence, D.L., Nelson, A.E., Kinlaw, W.B., Beyer, H.S., Nuttall, F.Q. & Shafer, R.B. (1983) Impotence in medical clinic outpatients. Journal of the American Medical Association, 249, 1736-1740.
89. Soderdahl, D.W., Thrasher, J.B. & Hansberry, K.L. (1997) Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. British Journal of Urology, 79, 952-957.
90. Speckens, A.E., Hengeveld, M.W., Lycklama a Nijeholt, G., van Hemert, A.M. & Hawton, K.E. (1995) Psychosexual functioning of partners of men with presumed non-organic erectile dysfunction: cause or consequence of the disorder? Achives of Sexual Behavior, 24, 157-172.
91. Stief, C.G., Benard, F., Bosch, R.J., Aboseif, S.R., Lue, T.F. & Tanagho, E.A. (1990) A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis. Journal of Urology, 143, 392-397.
92. Susset, J.G., Tessier, C.D., Wincze, J., Bansal, S., Malhotra, C. & Schwacha, M.G. (1989) Effect of Yohimbine hydrochloride on erectile impotence: a double-blind study. Journal of Urology, 141, 1360-1363.
93. Truss, M.C., Becker, A.J., Djamilian, M.H., Stief, C.G. & Jonas, U. (1994) Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. Urology, 44, 553-556.
94. Turner, L. A., Althof, S. E., Levine, S. B., Tobias, T. R., Kursh, E. D., Bodner, D. & Resnick, M. I. (1990) Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. Journal of Urology, 144, 79-82.
95. Virag, R. (1982) Intracavernous injection of papaverine for erectile failure. Lancet, 2, 938.
96. Vobig, M.A., Klotz, T., Staak, M., Bartz-Schmidt, K.U., Engelmann, U. & Walter, P. (1999) Retinal side-effects of sildenafil. Lancet, 353, 375.
97. Weiss, J.N., Badlani, G.H., Ravalli, R. & Brettschneider, N. (1994) Reasons for high drop-out rate with self-injection therapy for impotence. International Journal of Impotence Research, 6, 171-174.
98. Wessells, H., Fuciarelli, K., Hansen, J., Hadley, M.E., Hruby, V.J., Dorr, R. & Levine, N. (1998) Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. Journal of Urology, 160, 389-393.
99. Williams, G., Abbou, C.C., Amar, E.T., Desvaux, P., Flam, T.A., Lycklama, A., Nijeholt, G.A., Lynch, S.F., Morgan, R.J., Muller, S.C., Porst, H., Pryor, J.P., Ryan, P., Witzsch, U.K., Hall, M.M., Place, V.A., Spivack, A.P. & Gesundheit, N. (1998) Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group. British Journal of Urology, 81, 889-894.
100. Wylie, K.R. (1997) Male erectile disorder: characteristics and treatment choice of a longitudinal cohort study of men. International Journal of Impotence Research, 9, 217-224.
101. Zelefsky, M.J., McKee, A.B., Lee, H. & Leibel, S.A. (1999) Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology, 53, 775-778.
102. Zippe, C.D., Kedia, A.W., Kedia, K., Nelson, D.R. & Agarwal, A. (1998) Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology, 52, 963-966.
103. Zorgniotti, A.W. (1994) Experience with buccal phentolamine mesylate for impotence. International Journal of Impotence Research, 6, 37-41.